| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000022205 |
| Receipt No. | R000025578 |
| Scientific Title | The prognostic factor in heart failure patients |
| Date of disclosure of the study information | 2016/05/05 |
| Last modified on | 2021/11/08 (Ver. 4) |
| Basic information | ||
| Public title | The prognostic factor in heart failure patients | |
| Acronym | Prognostic factor in heart failure | |
| Scientific Title | The prognostic factor in heart failure patients | |
| Scientific Title:Acronym | Prognostic factor in heart failure | |
| Region |
|
|
| Condition | ||
| Condition | Heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigation of prognostic factor in heart failure patients |
| Basic objectives2 | Others |
| Basic objectives -Others | Observational study in heart failure patients and investigation of prognostic factor |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Cardiovascular events |
| Key secondary outcomes | All-cause death |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Hospitalized heart failure patients | |||
| Key exclusion criteria | patients with documented dementia, delirium, infections, depression during treatment, renal failure (serum creatinine >3 mg/dl), cancer, other severe non-cardiovascular diseases, or pacemaker or implantable cardioverter defibrillator implantation. | |||
| Target sample size | 800 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Jichi Medical University School of Medicine | ||||||
| Division name | Division of Cardiovascular Medicine, Department of Medicine | ||||||
| Zip code | 329-0498 | ||||||
| Address | 3311-1 Yakushiji Shimotsuke-shi Tochigi-ken | ||||||
| TEL | 0285-58-7344 | ||||||
| tkomori@jichi.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Jichi Medical University School of Medicine | ||||||
| Division name | Division of Cardiovascular Medicine, Department of Medicine | ||||||
| Zip code | 329-0498 | ||||||
| Address | 3311-1 Yakushiji Shimotsuke-shi Tochigi-ken | ||||||
| TEL | 0285-58-7344 | ||||||
| Homepage URL | |||||||
| tkomori@jichi.ac.jp | |||||||
| Sponsor | |
| Institute | Jichi Medical University School of Medicine, Division of Cardiovascular Medicine, Department of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Jichi Medical University School of Medicine |
| Address | 3311-1 Yakushiji Shimotsuke-shi Tochigi-ken |
| Tel | 0285-44-2111 |
| rksc_monitor@jichi.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | https://www.jstage.jst.go.jp/article/circj/81/2/81_CJ-16-0740/_article |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | The patients is followed-up for 3 years. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025578 |